ARK Genomic Revolution ETF Rating $25.61 +2.00 (+8.48%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$25.74 +0.13 (+0.52%) As of 09/12/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.68Holdings in ARKG have an aggregate rating of Moderate Buy based on 312 analyst ratings issued in the past year covering 25 companies (90.8% of the portfolio).ARKG Aggregate Price Target$25.61High Prediction$25.61Average Prediction$25.61Low Prediction$25.61Holdings in ARKG have an aggregate price target of $25.61 and a range of $25.61 to $25.61 covering 25 companies (90.8% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 ARKG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.21%TEMTempus AI$86.38-2.7%2.0484 of 5 stars2.54$70.17 -18.8%13Trending NewsAnalyst ForecastOptions Volume9.81%CRSPCRISPR Therapeutics$56.26+0.7%3.2872 of 5 stars2.47$71.60 27.3%17Positive News5.86%TWSTTwist Bioscience$25.31-1.2%3.98 of 5 stars2.73$49.40 95.2%11News Coverage5.72%RXRXRecursion Pharmaceuticals$4.83-0.4%2.1498 of 5 stars2.40$7.25 50.1%5News CoverageAnalyst ForecastOptions VolumeGap Up4.69%GHGuardant Health$54.90-3.3%4.091 of 5 stars3.06$58.24 6.1%18News CoveragePositive NewsInsider TradeGap Down4.49%NTRANatera$168.51-3.0%3.6584 of 5 stars3.06$194.00 15.1%18Positive News4.25%TXG10x Genomics$12.64-3.2%3.6195 of 5 stars2.33$13.65 8.0%15News CoverageAnalyst Forecast4.00%ADPTAdaptive Biotechnologies$12.61-6.5%3.6727 of 5 stars2.88$12.38 -1.9%8Positive News3.65%SDGRSchrodinger$18.57-1.1%3.385 of 5 stars2.67$27.83 49.9%6Positive News3.64%ILMNIllumina$95.12-4.2%4.8422 of 5 stars2.21$123.06 29.4%19Positive News3.59%PSNLPersonalis$5.85-4.1%4.0113 of 5 stars3.00$7.42 26.8%5News Coverage3.38%VCYTVeracyte$30.88-3.1%3.8512 of 5 stars2.70$40.90 32.4%10Positive News3.27%BEAMBeam Therapeutics$20.60-4.4%2.8529 of 5 stars3.08$46.40 125.2%133.00%ABSIAbsci$2.55-6.9%2.6464 of 5 stars3.00$7.98 212.9%5News CoveragePositive NewsGap Up2.91%NTLAIntellia Therapeutics$11.424.3185 of 5 stars2.56$27.11 137.4%18Positive NewsAnalyst Revision2.80%ARCTArcturus Therapeutics$17.32-4.0%3.1441 of 5 stars3.00$50.57 192.0%8Positive News2.69%IONSIonis Pharmaceuticals$63.16-1.4%3.6813 of 5 stars2.81$67.88 7.5%16Insider Trade2.51%CDNACareDx$13.534.303 of 5 stars2.57$25.50 88.5%7News CoveragePositive NewsAnalyst Forecast1.48%NRIXNurix Therapeutics$9.04-1.7%2.3805 of 5 stars2.88$29.07 221.6%16News CoveragePositive News1.47%PRMEPrime Medicine$4.07-0.2%3.2813 of 5 stars2.75$8.92 119.1%81.40%AMGNAmgen$276.39-2.2%4.6437 of 5 stars2.32$304.43 10.1%22Positive News1.39%PACBPacific Biosciences of California$1.17-7.1%2.7289 of 5 stars2.43$1.90 62.4%7Positive NewsHigh Trading Volume1.26%INCYIncyte$83.10-3.6%4.7553 of 5 stars2.33$82.53 -0.7%18Positive NewsAnalyst DowngradeShort Interest ↓1.21%MASS908 Devices$5.60-2.1%3.3928 of 5 stars3.25$8.00 42.9%4Positive News1.15%VEEVVeeva Systems$276.21-1.2%4.3706 of 5 stars2.60$301.48 9.1%25Positive News This page (BATS:ARKG) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARKG Stock Alerts